1
|
Pereira AC, Cunha AOS, Mortari MR, Fachim HA, Campos GAA, Lopes NP, Dos Santos WF. Antiepileptic profile of Parawixin-11, purified from Parawixia bistriata spider venom (Araneae, Araneidae), in Wistar rats. NAUNYN-SCHMIEDEBERG'S ARCHIVES OF PHARMACOLOGY 2024:10.1007/s00210-024-03299-x. [PMID: 39042155 DOI: 10.1007/s00210-024-03299-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2024] [Accepted: 07/12/2024] [Indexed: 07/24/2024]
Abstract
The pharmacological treatment of epilepsy is often complex due to the lack of efficacy in many patients and profound side effects from current drugs, including sedation, motor impairment, and teratogenesis. In the quest for new antiepileptic drugs, animal venoms offer a valuable source of neuroactive molecules targeting ion channels and neurotransmitter receptors. This study investigates the antiepileptic potential of compounds isolated from the venom of the Parawixia bistriata spider. One compound, designated Parawixin-11, demonstrated significant anticonvulsant effects when injected into the cerebral ventricle in a dose-response manner. It effectively countered seizures induced by bicuculline (ED50 0.16 µg/animal), pentylenetetrazole (ED50 0.08 µg/animal), strychnine (ED50 0.05 µg/animal), pilocarpine (ED50 0.10 µg/animal), and NMDA (ED50 0.008 µg/animal). We also assessed whether intracerebroventricular administration of Parawixin-11 caused motor or cognitive impairments in rats using the open field, rotarod, and Morris water maze tests. No differences in exploration or movement were observed with doses of 0.3, 0.2, or 0.1 µg of Parawixin-11. Although there was an increased latency to find the platform during the acquisition phase of the Morris water maze test, no differences in spatial memory retention were noted. Given Parawixin-11's potency against NMDA-induced seizures, we hypothesize that it may modulate the glutamatergic system, aligning with the mechanisms of several spider-derived polyamines.
Collapse
Affiliation(s)
- Adriana Colsera Pereira
- Neurobiology and Venoms Laboratory, Department of Biology, College of Philosophy, Sciences and Literature (FFCLRP), University of São Paulo (USP), Av. Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14040-090, Brazil
- Instituto de Neurociências e Comportamento (INeC), Ribeirão Preto, São Paulo, Brazil
| | - Alexandra Olimpio Siqueira Cunha
- Neurobiology and Venoms Laboratory, Department of Biology, College of Philosophy, Sciences and Literature (FFCLRP), University of São Paulo (USP), Av. Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14040-090, Brazil
- Instituto de Neurociências e Comportamento (INeC), Ribeirão Preto, São Paulo, Brazil
| | - Márcia Renata Mortari
- Neurobiology and Venoms Laboratory, Department of Biology, College of Philosophy, Sciences and Literature (FFCLRP), University of São Paulo (USP), Av. Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14040-090, Brazil
- Laboratory of Neuropharmacology, Department of Physiological Sciences, University of Brasilia (UnB), Brasilia, DF, Brazil
| | - Helene Aparecida Fachim
- Neurobiology and Venoms Laboratory, Department of Biology, College of Philosophy, Sciences and Literature (FFCLRP), University of São Paulo (USP), Av. Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14040-090, Brazil
- Instituto de Neurociências e Comportamento (INeC), Ribeirão Preto, São Paulo, Brazil
| | - Gabriel Avohay Alves Campos
- Laboratory of Neuropharmacology, Department of Physiological Sciences, University of Brasilia (UnB), Brasilia, DF, Brazil
| | - Norberto Peporine Lopes
- Organic Chemistry Laboratory, Department of Physics and Chemistry, Ribeirão Preto School of Pharmacy (FCFRP), University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil
| | - Wagner Ferreira Dos Santos
- Neurobiology and Venoms Laboratory, Department of Biology, College of Philosophy, Sciences and Literature (FFCLRP), University of São Paulo (USP), Av. Bandeirantes, 3900, Ribeirão Preto, São Paulo, CEP: 14040-090, Brazil.
- Instituto de Neurociências e Comportamento (INeC), Ribeirão Preto, São Paulo, Brazil.
| |
Collapse
|
2
|
Zainal Abidin SA, Liew AKY, Othman I, Shaikh F. Animal Venoms as Potential Source of Anticonvulsants. F1000Res 2024; 13:225. [PMID: 38919947 PMCID: PMC11196940 DOI: 10.12688/f1000research.147027.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/27/2024] [Indexed: 06/27/2024] Open
Abstract
Epilepsy affects millions of people worldwide, and there is an urgent need to develop safe and effective therapeutic agents. Animal venoms contain diverse bioactive compounds like proteins, peptides, and small molecules, which may possess medicinal properties against epilepsy. In recent years, research has shown that venoms from various organisms such as spiders, ants, bees, wasps, and conus snails have anticonvulsant and antiepileptic effects by targeting specific receptors and ion channels. This review underscores the significance of purified proteins and toxins from these sources as potential therapeutic agents for epilepsy. In conclusion, this review emphasizes the valuable role of animal venoms as a natural resource for further exploration in epilepsy treatment research.
Collapse
Affiliation(s)
- Syafiq Asnawi Zainal Abidin
- Monash University Malaysia, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Bandar Sunway, Selangor, 47500, Malaysia
| | - Anthony Kin Yip Liew
- Monash University Malaysia, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Bandar Sunway, Selangor, 47500, Malaysia
| | - Iekhsan Othman
- Monash University Malaysia, Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Bandar Sunway, Selangor, 47500, Malaysia
| | - Farooq Shaikh
- School of Dentistry and Medical Sciences, Charles Sturt University, Orange, New South Wales, 2800, Australia
| |
Collapse
|
3
|
Saima, Latha S, Sharma R, Kumar A. Role of Network Pharmacology in Prediction of Mechanism of Neuroprotective Compounds. Methods Mol Biol 2024; 2761:159-179. [PMID: 38427237 DOI: 10.1007/978-1-0716-3662-6_13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2024]
Abstract
Network pharmacology is an emerging pioneering approach in the drug discovery process, which is used to predict the therapeutic mechanism of compounds using various bioinformatic tools and databases. Emerging studies have indicated the use of network pharmacological approaches in various research fields, particularly in the identification of possible mechanisms of herbal compounds/ayurvedic formulations in the management of various diseases. These techniques could also play an important role in the prediction of the possible mechanisms of neuroprotective compounds. The first part of the chapter includes an introduction on neuroprotective compounds based on literature. Further, network pharmacological approaches are briefly discussed. The use of network pharmacology in the prediction of the neuroprotective mechanism of compounds is discussed in detail with suitable examples. Finally, the chapter concludes with the current challenges and future prospectives.
Collapse
Affiliation(s)
- Saima
- Department of Pharmacology, Delhi Pharmaceutical Science and Research University (DPSRU), New Delhi, India
| | - S Latha
- Department of Pharmacology, Delhi Pharmaceutical Science and Research University (DPSRU), New Delhi, India
| | - Ruchika Sharma
- Centre for Precision Medicine and Pharmacy, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, India
| | - Anoop Kumar
- Department of Pharmacology, Delhi Pharmaceutical Science and Research University (DPSRU), New Delhi, India
| |
Collapse
|
4
|
Lima LSD, Loyola V, Bicca JVML, Faro L, Vale CLC, Lotufo Denucci B, Mortari MR. Innovative treatments for epilepsy: Venom peptides, cannabinoids, and neurostimulation. J Neurosci Res 2022; 100:1969-1986. [PMID: 35934922 DOI: 10.1002/jnr.25114] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Revised: 07/13/2022] [Accepted: 07/22/2022] [Indexed: 11/07/2022]
Abstract
Antiepileptic drugs have been successfully treating epilepsy and providing individuals sustained seizure freedom. However, about 30% of the patients with epilepsy present drug resistance, which means they are not responsive to the pharmacological treatment. Considering this, it becomes extremely relevant to pursue alternative therapeutic approaches, in order to provide appropriate treatment for those patients and also improve their quality of life. In the light of that, this review aims to discuss some innovative options for the treatment of epilepsy, which are currently under investigation, addressing strategies that go from therapeutic compounds to clinical procedures. For instance, peptides derived from animal venoms, such as wasps, spiders, and scorpions, demonstrate to be promising antiepileptic molecules, acting on a variety of targets. Other options are cannabinoids and compounds that modulate the endocannabinoid system, since it is now known that this network is involved in the pathophysiology of epilepsy. Furthermore, neurostimulation is another strategy, being an alternative clinical procedure for drug-resistant patients who are not eligible for palliative surgeries.
Collapse
Affiliation(s)
- Larissa Silva de Lima
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Vinícius Loyola
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - João Victor Montenegro Luzardo Bicca
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Lucas Faro
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Camilla Lepesqueur Costa Vale
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Bruna Lotufo Denucci
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| | - Márcia Renata Mortari
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasilia, Brasilia, Brazil
| |
Collapse
|
5
|
Green JL, Dos Santos WF, Fontana ACK. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development. Biochem Pharmacol 2021; 193:114786. [PMID: 34571003 DOI: 10.1016/j.bcp.2021.114786] [Citation(s) in RCA: 47] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2021] [Revised: 09/21/2021] [Accepted: 09/22/2021] [Indexed: 12/21/2022]
Abstract
Epilepsy is a complex neurological syndrome characterized by seizures resulting from neuronal hyperexcitability and sudden and synchronized bursts of electrical discharges. Impaired astrocyte function that results in glutamate excitotoxicity has been recognized to play a key role in the pathogenesis of epilepsy. While there are 26 drugs marketed as anti-epileptic drugs no current treatments are disease modifying as they only suppress seizures rather than the development and progression of epilepsy. Excitatory amino acid transporters (EAATs) are critical for maintaining low extracellular glutamate concentrations and preventing excitotoxicity. When extracellular glutamate concentrations rise to abnormal levels, glutamate receptor overactivation and the subsequent excessive influx of calcium into the post-synaptic neuron can trigger cell death pathways. In this review we discuss targeting EAAT2, the predominant glutamate transporter in the CNS, as a promising approach for developing therapies for epilepsy. EAAT2 upregulation via transcriptional and translational regulation has proven successful in vivo in reducing spontaneous recurrent seizures and offering neuroprotective effects. Another approach to regulate EAAT2 activity is through positive allosteric modulation (PAM). Novel PAMs of EAAT2 have recently been identified and are under development, representing a promising approach for the advance of novel therapeutics for epilepsy.
Collapse
Affiliation(s)
- Jennifer Leigh Green
- Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, 19102, United States
| | | | | |
Collapse
|
6
|
Forster YM, Green JL, Khatiwada A, Liberato JL, Narayana Reddy PA, Salvino JM, Bienz S, Bigler L, dos Santos WF, Karklin Fontana AC. Elucidation of the Structure and Synthesis of Neuroprotective Low Molecular Mass Components of the Parawixia bistriata Spider Venom. ACS Chem Neurosci 2020; 11:1573-1596. [PMID: 32343555 DOI: 10.1021/acschemneuro.0c00007] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
The South American social spider Parawixia bistriata produces a venom containing complex organic compounds with intriguing biological activities. The crude venom leads to paralysis in termites and stimulates l-glutamate uptake and inhibits GABA uptake in rat brain synaptosomes. Glutamate is the major neurotransmitter at the insect neuromuscular junction and at the mammalian central nervous system, suggesting a modulation of the glutamatergic system by the venom. Parawixin1, 2, and 10 (Pwx1, 2 and 10) are HPLC fractions that demonstrate this bioactivity. Pwx1 stimulates l-glutamate uptake through the main transporter in the brain, EAAT2, and is neuroprotective in in vivo glaucoma models. Pxw2 inhibits GABA and glycine uptake in synaptosomes and inhibits seizures and neurodegeneration, and Pwx10 increases l-glutamate uptake in synaptosomes and is neuroprotective and anticonvulsant, shown in in vivo epilepsy models. Herein, we investigated the low molecular mass compounds in this venom and have found over 20 small compounds and 36 unique acylpolyamines with and without amino acid linkers. The active substances in fractions Pwx1 and Pwx2 require further investigation. We elucidated and confirmed the structure of the active acylpolyamine in Pwx10. Both fraction Pwx10 and the synthesized component enhance the activity of transporters EAAT1 and EAAT2, and, importantly, offer in vitro neuroprotection against excitotoxicity in primary cultures. These data suggest that compounds with this mechanism could be developed into therapies for disorders in which l-glutamate excitotoxicity is involved.
Collapse
Affiliation(s)
- Yvonne M. Forster
- Department of Chemistry, University of Zurich, Zurich, CH 8057, Switzerland
| | - Jennifer Leigh Green
- Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States
| | - Apeksha Khatiwada
- Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States
| | - José Luiz Liberato
- Department of Biology, University of São Paulo, Ribeirão Preto, SP 14040-900, Brazil
| | | | - Joseph M. Salvino
- The Wistar Institute, Philadelphia, Pennsylvania 19104, United States
| | - Stefan Bienz
- Department of Chemistry, University of Zurich, Zurich, CH 8057, Switzerland
| | - Laurent Bigler
- Department of Chemistry, University of Zurich, Zurich, CH 8057, Switzerland
| | | | - Andréia Cristina Karklin Fontana
- Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, United States
| |
Collapse
|
7
|
Mohd Sairazi NS, Sirajudeen KNS. Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE : ECAM 2020; 2020:6565396. [PMID: 32148547 PMCID: PMC7042511 DOI: 10.1155/2020/6565396] [Citation(s) in RCA: 65] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/25/2019] [Revised: 12/09/2019] [Accepted: 01/06/2020] [Indexed: 02/06/2023]
Abstract
In recent years, natural products, which originate from plants, animals, and fungi, together with their bioactive compounds have been intensively explored and studied for their therapeutic potentials for various diseases such as cardiovascular, diabetes, hypertension, reproductive, cancer, and neurodegenerative diseases. Neurodegenerative diseases, including Alzheimer's disease, Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis are characterized by the progressive dysfunction and loss of neuronal structure and function that resulted in the neuronal cell death. Since the multifactorial pathological mechanisms are associated with neurodegeneration, targeting multiple mechanisms of actions and neuroprotection approach, which involves preventing cell death and restoring the function to damaged neurons, could be promising strategies for the prevention and therapeutic of neurodegenerative diseases. Natural products have emerged as potential neuroprotective agents for the treatment of neurodegenerative diseases. This review focused on the therapeutic potential of natural products and their bioactive compounds to exert a neuroprotective effect on the pathologies of neurodegenerative diseases.
Collapse
Affiliation(s)
- Nur Shafika Mohd Sairazi
- Faculty of Medicine, Universiti Sultan Zainal Abidin (UniSZA), Medical Campus, Jalan Sultan Mahmud, 20400 Kuala Terengganu, Terengganu, Malaysia
| | - K. N. S. Sirajudeen
- Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
- Department of Basic Medical Sciences, Kulliyyah of Medicine, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia
| |
Collapse
|
8
|
Primini EO, Liberato JL, Fontana ACK, dos Santos WF. Neuroprotective properties of RT10, a fraction isolated from Parawixia bistriata spider venom, against excitotoxicity injury in neuron-glia cultures. J Venom Anim Toxins Incl Trop Dis 2019; 25:e148818. [PMID: 31131008 PMCID: PMC6533932 DOI: 10.1590/1678-9199-jvatitd-1488-18] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2018] [Accepted: 01/15/2019] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND L-Glutamate (L-Glu), the major excitatory neurotransmitter in the mammalian Central Nervous System (CNS), is essential to cognitive functions. However, when L-Glu is accumulated in large concentrations at the synaptic cleft, it can induce excitotoxicity that results in secondary damage implicated in many neurological disorders. Current therapies for the treatment of neurological disorders are ineffective and have side effects associated with their use; therefore, there is a need to develop novel treatments. In this regard, previous studies have shown that neuroactive compounds obtained from the venom of the spider Parawixia bistriata have neuroprotective effects in vitro and in vivo. In this sense, this work aimed to evaluate potential neuroprotective effects of fraction RT10, obtained from this spider venom, on primary cultures of neuron and glial cells subjected to glutamate excitotoxicity insults. METHODS Primary cultures of neurons and glia were obtained from the cerebral tissue of 1-day-old postnatal Wistar rats. After 7 days in vitro (DIV), the cultures were incubated with fraction RT10 (0.002; 0.02; 0.2 and 2 µg/µL) or riluzole (100 µM) for 3-hours before application of 5 mM L-Glu. After 12 hours, the resazurin sodium salt (RSS) test was applied to measure metabolic activity and proliferation of living cells, whereas immunocytochemistry for MAP2 was performed to measure neuronal survival. In addition, the cells were immunolabeled with NeuN and GFAP in baseline conditions. RESULTS In the RSS tests, we observed that pre-incubation with RT10 before the excitotoxic insults from L-Glu resulted in neuroprotection, shown by a 10% reduction in the cell death level. RT10 was more effective than riluzole, which resulted in a cell-death reduction of 5%. Moreover, qualitative analysis of neuronal morphology (by MAP2 staining, expressed as fluorescence intensity (FI), an indirect measure of neuronal survival) indicate that RT10 reduced the toxic effects of L-Glu, as shown by a 38 % increase in MAP2 fluorescence when compared to L-Glu insult. On the other hand, the riluzole treatment resulted in 17% increase of MAP2 fluorescence; therefore, the neuroprotection from RT10 was more efficacious. CONCLUSION RT10 fraction exhibits neuroprotective effects against L-Glu excitotoxicity in neuron-glia cultured in vitro.
Collapse
Affiliation(s)
- Eduardo Octaviano Primini
- Neurobiology and Venoms Laboratory, Department of Biology, College
of Philosophy, Sciences and Literature of Ribeirão Preto, University of São Paulo,
Ribeirão Preto, SP, Brazil
| | - José Luiz Liberato
- Neurobiology and Venoms Laboratory, Department of Biology, College
of Philosophy, Sciences and Literature of Ribeirão Preto, University of São Paulo,
Ribeirão Preto, SP, Brazil
- Institute for Neurosciences and Behavior - INeC, Ribeirão Preto, SP,
Brazil
| | | | - Wagner Ferreira dos Santos
- Neurobiology and Venoms Laboratory, Department of Biology, College
of Philosophy, Sciences and Literature of Ribeirão Preto, University of São Paulo,
Ribeirão Preto, SP, Brazil
- Institute for Neurosciences and Behavior - INeC, Ribeirão Preto, SP,
Brazil
| |
Collapse
|
9
|
Scharff N, Coddington JA, Blackledge TA, Agnarsson I, Framenau VW, Szűts T, Hayashi CY, Dimitrov D. Phylogeny of the orb‐weaving spider family Araneidae (Araneae: Araneoidea). Cladistics 2019; 36:1-21. [DOI: 10.1111/cla.12382] [Citation(s) in RCA: 45] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/11/2019] [Indexed: 11/29/2022] Open
Affiliation(s)
- Nikolaj Scharff
- Center for Macroecology, Evolution and Climate Natural History Museum of Denmark University of Copenhagen Copenhagen Denmark
- Smithsonian Institution National Museum of Natural History 10th and Constitution NW Washington DC 20560‐0105 USA
| | - Jonathan A. Coddington
- Smithsonian Institution National Museum of Natural History 10th and Constitution NW Washington DC 20560‐0105 USA
| | - Todd A. Blackledge
- Integrated Bioscience Program Department of Biology University of Akron Akron OH USA
| | - Ingi Agnarsson
- Smithsonian Institution National Museum of Natural History 10th and Constitution NW Washington DC 20560‐0105 USA
- Department of Biology University of Vermont 109 Carrigan Drive Burlington VT 05405‐0086 USA
| | - Volker W. Framenau
- Department of Terrestrial Zoology Western Australian Museum Locked Bag 49 Welshpool DC WA 6986 Australia
- School of Animal Biology University of Western Australia Crawley WA 6009 Australia
- Harry Butler Institute Murdoch University 90 South St. Murdoch WA 6150 Australia
| | - Tamás Szűts
- Center for Macroecology, Evolution and Climate Natural History Museum of Denmark University of Copenhagen Copenhagen Denmark
- Department of Ecology University of Veterinary Medicine Budapest H1077 Budapest Hungary
| | - Cheryl Y. Hayashi
- Division of Invertebrate Zoology and Sackler Institute for Comparative Genomics American Museum of Natural History New York NY 10024 USA
| | - Dimitar Dimitrov
- Center for Macroecology, Evolution and Climate Natural History Museum of Denmark University of Copenhagen Copenhagen Denmark
- Natural History Museum University of Oslo PO Box 1172, Blindern NO‐0318 Oslo Norway
- Department of Natural History University Museum of Bergen University of Bergen Bergen Norway
| |
Collapse
|
10
|
Baldo MA, Cunha AOS, Godoy LD, Liberato JL, Yoneda JS, Fornari-Baldo EC, Ciancaglini P, dos Santos WF, Arantes EC. Assessment of neuropharmacological potential of low molecular weight components extracted from Rhinella schneideri toad poison. J Venom Anim Toxins Incl Trop Dis 2019; 25:e148418. [PMID: 31131006 PMCID: PMC6483406 DOI: 10.1590/1678-9199-jvatitd-1484-18] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Accepted: 10/23/2018] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND Studies on toad poison are relevant since they are considered a good source of toxins that act on different biological systems. Among the molecules found in the toad poison, it can be highlighted the cardiotonic heterosides, which have a known mechanism that inhibit Na+/K+-ATPase enzyme. However, these poisons have many other molecules that may have important biological actions. Therefore, this work evaluated the action of the low molecular weight components from Rhinella schneideri toad poison on Na+/K+-ATPase and their anticonvulsive and / or neurotoxic effects, in order to detect molecules with actions of biotechnological interest. METHODS Rhinella schneideri toad (male and female) poison was collected by pressuring their parotoid glands and immediately dried and stored at -20 °C. The poison was dialysed and the water containing the low molecular mass molecules (< 8 kDa) that permeate the dialysis membrane was collected, frozen and lyophilized, resulting in the sample used in the assays, named low molecular weight fraction (LMWF). Na+/K+ ATPase was isolated from rabbit kidneys and enzyme activity assays performed by the quantification of phosphate released due to enzyme activity in the presence of LMWF (1.0; 10; 50 and 100 µg/mL) from Rhinella schneideri poison. Evaluation of the L-Glutamate (L-Glu) excitatory amino acid uptake in brain-cortical synaptosomes of Wistar rats was performed using [3H]L-glutamate and different concentration of LMWF (10-5 to 10 µg/µL). Anticonvulsant assays were performed using pentylenetetrazole (PTZ) and N-methyl-D-aspartate (NMDA) to induce seizures in Wistar rats (n= 6), which were cannulated in the lateral ventricle and treated with different concentration of LMWF (0.25; 0.5; 1.0; 2.0; 3.0 and 4.0 µg/µL) 15 min prior to the injection of the seizure agent. RESULTS LMWF induced a concentration-dependent inhibition of Na+/K+-ATPase (IC50% = 107.5 μg/mL). The poison induces an increased uptake of the amino acid L-glutamate in brain-cortical synaptosomes of Wistar rats. This increase in the L-glutamate uptake was observed mainly at the lowest concentrations tested (10-5 to 10-2 µg/µL). In addition, this fraction showed a very relevant central neuroprotection on seizures induced by PTZ and NMDA. CONCLUSIONS LMWF from Rhinella schneideri poison has low molecular weight compounds, which were able to inhibit Na+/K+-ATPase activity, increase the L-glutamate uptake and reduced seizures induced by PTZ and NMDA. These results showed that LMWF is a rich source of components with biological functions of high medical and scientific interest.
Collapse
Affiliation(s)
- Mateus Amaral Baldo
- Department of Physics and Chemistry, Ribeirão Preto College of
Pharmaceutical Science, University of São Paulo, Ribeirão Preto, SP, Brazil
- Health and Science Institute, Paulista University, São Paulo, SP,
Brazil
| | - Alexandra Olimpio Siqueira Cunha
- Neurobiology and Venoms Laboratory, Department of Biology, Faculty
of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo,
Ribeirão Preto, SP, Brazil
| | - Lívea Dornela Godoy
- Neurobiology and Venoms Laboratory, Department of Biology, Faculty
of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo,
Ribeirão Preto, SP, Brazil
- Institute of Neurosciences & Behavior - INeC, Campus USP,
Ribeirão Preto, SP, Brazil
| | - José Luiz Liberato
- Neurobiology and Venoms Laboratory, Department of Biology, Faculty
of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo,
Ribeirão Preto, SP, Brazil
- Institute of Neurosciences & Behavior - INeC, Campus USP,
Ribeirão Preto, SP, Brazil
| | - Juliana Sakamoto Yoneda
- Department of Chemistry, Faculty of Philosophy, Sciences and Letters
at Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
| | - Elisa Correa Fornari-Baldo
- Department of Physics and Chemistry, Ribeirão Preto College of
Pharmaceutical Science, University of São Paulo, Ribeirão Preto, SP, Brazil
- Health and Science Institute, Paulista University, São Paulo, SP,
Brazil
| | - Pietro Ciancaglini
- Department of Chemistry, Faculty of Philosophy, Sciences and Letters
at Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
| | - Wagner Ferreira dos Santos
- Neurobiology and Venoms Laboratory, Department of Biology, Faculty
of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo,
Ribeirão Preto, SP, Brazil
- Institute of Neurosciences & Behavior - INeC, Campus USP,
Ribeirão Preto, SP, Brazil
| | - Eliane Candiani Arantes
- Department of Physics and Chemistry, Ribeirão Preto College of
Pharmaceutical Science, University of São Paulo, Ribeirão Preto, SP, Brazil
| |
Collapse
|
11
|
Matias I, Elias-Filho DH, Garcia CAB, Silva GH, Mejia J, Cabral FR, Miranda ACC, Gomes da Silva S, da Silva Lopes L, Coimbra NC, Machado HR. A new model of experimental hemispherotomy in young adult Rattus norvegicus: a neural tract tracing and SPECT in vivo study. J Neurosurg 2019; 130:1210-1223. [PMID: 29882701 DOI: 10.3171/2017.12.jns171150] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2017] [Accepted: 12/11/2017] [Indexed: 01/13/2023]
Abstract
OBJECTIVE The objective of this study was to describe a new experimental model of hemispherotomy performed on laboratory animals. METHODS Twenty-six male young adult Wistar rats were distributed into two groups (surgery and control). The nonfluorescent anterograde neurotracer biotinylated dextran amine (BDA; 10,000 MW) was microinjected into the motor cortex area (M1) according to The Rat Brain in Stereotaxic Coordinates atlas to identify pathways and fibers disconnected after the experimental hemispherectomy. SPECT tomographic images of 99mTc hexamethylpropyleneamine oxime were obtained to verify perfusion in functioning areas of the disconnected and intact brain. A reproducible and validated surgical procedure is described in detail, including exact measurements and anatomical relationships. An additional 30 rodents (n = 10 rats per group) were divided into naïve, sham, and hemispherotomy groups and underwent the rotarod test. RESULTS Cortico-cortical neural pathways were identified crossing the midline and contacting neuronal perikarya in the contralateral brain hemisphere in controls, but not in animals undergoing hemispherotomy. There was an absence of perfusion in the left side of the brain of the animals undergoing hemispherotomy. Motor performance was significantly affected by brain injuries, increasing the number of attempts to maintain balance on the moving cylinder in the rotarod test at 10 and 30 days after the hemispherotomy, with a tendency to minimize the motor performance deficit over time. CONCLUSIONS The present findings show that the technique reproduced neural disconnection with minimal resection of brain parenchyma in young adult rats, thereby duplicating the hemispherotomy procedures in human patients.
Collapse
Affiliation(s)
- Ivair Matias
- 1Laboratory of Pediatric Neurosurgery and Developmental Neuropathology, Department of Surgery and Anatomy
- 2Laboratory of Neuroanatomy and Neuropsychobiology, Department of Pharmacology, and
| | | | | | - Guilherme Henrique Silva
- 1Laboratory of Pediatric Neurosurgery and Developmental Neuropathology, Department of Surgery and Anatomy
| | | | | | | | - Sérgio Gomes da Silva
- 3Hospital Israelita Albert Einstein; and
- 5Núcleo de Pesquisas Tecnológicas (NPT), Universidade de Mogi das Cruzes, São Paulo, Brazil
| | - Luíza da Silva Lopes
- 1Laboratory of Pediatric Neurosurgery and Developmental Neuropathology, Department of Surgery and Anatomy
| | - Norberto Cysne Coimbra
- 2Laboratory of Neuroanatomy and Neuropsychobiology, Department of Pharmacology, and
- 4Neuroelectrophysiology Multiuser Centre and Neurobiology of Pain and Emotions Laboratory, Department of Surgery and Anatomy, Ribeirão Preto Medical School of the University of São Paulo
| | - Hélio Rubens Machado
- 1Laboratory of Pediatric Neurosurgery and Developmental Neuropathology, Department of Surgery and Anatomy
- 4Neuroelectrophysiology Multiuser Centre and Neurobiology of Pain and Emotions Laboratory, Department of Surgery and Anatomy, Ribeirão Preto Medical School of the University of São Paulo
| |
Collapse
|
12
|
Nôga DAMF, Brandão LEM, Cagni FC, Silva D, de Azevedo DLO, Araújo A, Dos Santos WF, Miranda A, da Silva RH, Ribeiro AM. Anticonvulsant Effects of Fractions Isolated from Dinoponera quadriceps (Kempt) Ant Venom (Formicidae: Ponerinae). Toxins (Basel) 2016; 9:toxins9010005. [PMID: 28025529 PMCID: PMC5308238 DOI: 10.3390/toxins9010005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Revised: 10/24/2016] [Accepted: 11/01/2016] [Indexed: 12/13/2022] Open
Abstract
Natural products, sources of new pharmacological substances, have large chemical diversity and architectural complexity. In this context, some toxins obtained from invertebrate venoms have anticonvulsant effects. Epilepsy is a neurological disorder that affects about 65 million people worldwide, and approximately 30% of cases are resistant to pharmacological treatment. Previous studies from our group show that the denatured venom of the ant Dinoponera quadriceps (Kempt) protects mice against bicuculline (BIC)-induced seizures and death. The aim of this study was to investigate the anticonvulsant activity of compounds isolated from D. quadriceps venom against seizures induced by BIC in mice. Crude venom was fractionated by high-performance liquid chromatography (HPLC) resulting in six fractions referred to as DqTx1-DqTx6. A liquid chromatography-mass spectrometry (LC/MS) analysis revealed a major 431 Da compound in fractions DqTx1 and DqTx2. Fractions DqTx3 and DqTx4 showed a compound of 2451 Da and DqTx5 revealed a 2436 Da compound. Furthermore, the DqTx6 fraction exhibited a major component with a molecular weight of 13,196 Da. Each fraction (1 mg/mL) was microinjected into the lateral ventricle of mice, and the animals were observed in an open field. We did not observe behavioral alterations when the fractions were given alone. Conversely, when the fractions were microinjected 20 min prior to the administration of BIC (21.6 nM), DqTx1, DqTx4, and DqTx6 fractions increased the latency for onset of tonic-clonic seizures. Moreover, all fractions, except DqTx5, increased latency to death. The more relevant result was obtained with the DqTx6 fraction, which protected 62.5% of the animals against tonic-clonic seizures. Furthermore, this fraction protected 100% of the animals from seizure episodes followed by death. Taken together, these findings indicate that compounds from ant venom might be a potential source of new anticonvulsants molecules.
Collapse
Affiliation(s)
| | | | - Fernanda Carvalho Cagni
- Physiology Department, University Federal of Rio Grande of Norte, Natal, RN 59078-970, Brazil.
| | - Delano Silva
- Physiology Department, University Federal of Rio Grande of Norte, Natal, RN 59078-970, Brazil.
| | | | - Arrilton Araújo
- Physiology Department, University Federal of Rio Grande of Norte, Natal, RN 59078-970, Brazil.
| | | | - Antonio Miranda
- Biophysics Department, Federal University of São Paulo, São Paulo, SP 04023-062, Brazil.
| | - Regina Helena da Silva
- Pharmacology Department, Federal University of São Paulo, São Paulo, SP 04023-062, Brazil.
| | | |
Collapse
|
13
|
Monge-Fuentes V, Gomes FMM, Campos GAA, Silva JDC, Biolchi AM, Dos Anjos LC, Gonçalves JC, Lopes KS, Mortari MR. Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders. J Venom Anim Toxins Incl Trop Dis 2015; 21:31. [PMID: 26257776 PMCID: PMC4529710 DOI: 10.1186/s40409-015-0031-x] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2014] [Accepted: 07/28/2015] [Indexed: 01/25/2023] Open
Abstract
The impact of neurological disorders in society is growing with alarming estimations for an incidence increase in the next decades. These disorders are generally chronic and can affect individuals early during productive life, imposing real limitations on the performance of their social roles. Patients can have their independence, autonomy, freedom, self-image, and self-confidence affected. In spite of their availability, drugs for the treatment of these disorders are commonly associated with side effects, which can vary in frequency and severity. Currently, no effective cure is known. Nowadays, the biopharmaceutical research community widely recognizes arthropod venoms as a rich source of bioactive compounds, providing a plethora of possibilities for the discovery of new neuroactive compounds, opening up novel and attractive opportunities in this field. Several identified molecules with a neuropharmacological profile can act in the central nervous system on different neuronal targets, rendering them useful tools for the study of neurological disorders. In this context, this review aims to describe the current main compounds extracted from arthropod venoms for the treatment of five major existing neurological disorders: stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, and pathological anxiety.
Collapse
Affiliation(s)
- Victoria Monge-Fuentes
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| | - Flávia Maria Medeiros Gomes
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| | - Gabriel Avohay Alves Campos
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| | - Juliana de Castro Silva
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| | - Andréia Mayer Biolchi
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| | - Lilian Carneiro Dos Anjos
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| | - Jacqueline Coimbra Gonçalves
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| | - Kamila Soares Lopes
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| | - Márcia Renata Mortari
- Laboratory of Neuropharmacology, Department of Physiological Sciences, Institute of Biological Sciences, University of Brasília, DF CEP 70.910-900, Brasília, Brazil
| |
Collapse
|
14
|
Fachim HA, Mortari MR, Gobbo-Netto L, Dos Santos WF. Neuroprotective activity of parawixin 10, a compound isolated from Parawixia bistriata spider venom (Araneidae: Araneae) in rats undergoing intrahippocampal NMDA microinjection. Pharmacogn Mag 2015; 11:579-85. [PMID: 26246735 PMCID: PMC4522846 DOI: 10.4103/0973-1296.160450] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2014] [Revised: 08/10/2014] [Accepted: 07/10/2015] [Indexed: 12/22/2022] Open
Abstract
Background: Parawixia bistriata is a semi-colonial spider found mainly in southeastern of Brazil. Parawixin 10 (Pwx 10) a compound isolated from this spider venom has been demonstrated to act as neuroprotective in models of injury regulating the glutamatergic neurotransmission through glutamate transporters. Objectives: The aim of this work was to evaluate the neuroprotective effect of Pwx 10 in a rat model of excitotoxic brain injury by N-methyl-D-aspartate (NMDA) injection. Material and Methods: Male Wistar rats have been used, submitted to stereotaxic surgery for saline or NMDA microinjection into dorsal hippocampus. Two groups of animals were treated with Pwx 10. These treated groups received a daily injection of the Pwx 10 (2.5 mg/μL) in the right lateral ventricle into rats pretreated with NMDA, always at the same time, each one starting the treatment 1 h or 24 h. Nissl staining was performed for evaluating the extension and efficacy of the NMDA injury and the neuroprotective effect of Pwx 10. Results: The treatment with Pwx 10 showed neuroprotective effect, being most pronounced when the compound was administrated from 1 h after NMDA in all hippocampal subfields analyzed (CA1, CA3 and hilus). Conclusion: These results indicated that Pwx 10 may be a good template to develop therapeutic drugs for treating neurodegenerative diseases, reinforcing the importance of continuing studies on its effects in the central nervous system.
Collapse
Affiliation(s)
- Helene Aparecida Fachim
- Department of Biology, Neurobiology and Venoms Laboratory, FFCLRP, Brazil ; Institute of Neuroscience and Behavior, INeC-Ribeirão Preto, São Paulo, Brazil
| | - Marcia Renata Mortari
- Department of Physiological Sciences, Laboratory of Neuropharmacology, Institute of Biological Sciences, University of Brasilia, Campus Universitário Darcy Ribeiro, 70910-900 Brasília, DF, Brazil
| | - Leonardo Gobbo-Netto
- Department of Physics and Chemistry, Organic Chemistry Laboratory, FCFRP, University of São Paulo, Brazil
| | - Wagner Ferreira Dos Santos
- Department of Biology, Neurobiology and Venoms Laboratory, FFCLRP, Brazil ; Institute of Neuroscience and Behavior, INeC-Ribeirão Preto, São Paulo, Brazil
| |
Collapse
|
15
|
Nôga DAMF, Cagni FC, Santos JR, Silva D, Azevedo DLO, Araújo A, Silva RH, Ribeiro AM. Pro- and Anticonvulsant Effects of the Ant Dinoponera quadriceps (Kempf) Venom in Mice. NEOTROPICAL ENTOMOLOGY 2015; 44:410-417. [PMID: 26045053 DOI: 10.1007/s13744-015-0292-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/25/2014] [Accepted: 03/18/2015] [Indexed: 06/04/2023]
Abstract
Epilepsy affects at least 50 million people worldwide, and the available treatment is associated with various side effects. Approximately 20-30% of the patients develop seizures that persist despite careful monitored treatment with antiepileptic drugs. Thus, there is a clear need for the development of new antiepileptic drugs, and the venoms can be an excellent source of probes. In this context, while there are studies on venoms from snakes, scorpions, and spiders, little is known regarding venom from ants. The aim of this study was to investigate the potential pro- and anticonvulsant effects of the venom from the ant Dinoponera quadriceps (Kempf) in Swiss mice. After the injection of the crude venom (DqTx-5, 50, and 500 mg/mL) in the lateral ventricle of mice, we observed a reduction of exploration and grooming behaviors, as well as an increase in immobility duration. In addition, the crude venom induced procursive behavior and tonic-clonic seizures at the highest concentration. Conversely, the preadministration of the denatured venom (AbDq) at the concentration of 2 mg/mL protected the animals against tonic-clonic seizures (66.7%) and death (100%) induced by administration of bicuculline. Taken together, the findings demonstrate that D. quadriceps venom might be potential source of new pro- and anticonvulsants molecules.
Collapse
Affiliation(s)
- D A M F Nôga
- Depto de Fisiologia, Univ Federal do Rio Grande do Norte, Natal, RN, Brasil
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Biochemical and functional characterization of Parawixia bistriata spider venom with potential proteolytic and larvicidal activities. BIOMED RESEARCH INTERNATIONAL 2014; 2014:950538. [PMID: 24895632 PMCID: PMC4033418 DOI: 10.1155/2014/950538] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/20/2013] [Revised: 02/19/2014] [Accepted: 02/20/2014] [Indexed: 01/30/2023]
Abstract
Toxins purified from the venom of spiders have high potential to be studied pharmacologically and biochemically. These biomolecules may have biotechnological and therapeutic applications. This study aimed to evaluate the protein content of Parawixia bistriata venom and functionally characterize its proteins that have potential for biotechnological applications. The crude venom showed no phospholipase, hemorrhagic, or anti-Leishmania activities attesting to low genotoxicity and discrete antifungal activity for C. albicans. However the following activities were observed: anticoagulation, edema, myotoxicity and proteolysis on casein, azo-collagen, and fibrinogen. The chromatographic and electrophoretic profiles of the proteins revealed a predominance of acidic, neutral, and polar proteins, highlighting the presence of proteins with high molecular masses. Five fractions were collected using cation exchange chromatography, with the P4 fraction standing out as that of the highest purity. All fractions showed proteolytic activity. The crude venom and fractions P1, P2, and P3 showed larvicidal effects on A. aegypti. Fraction P4 showed the presence of a possible metalloprotease (60 kDa) that has high proteolytic activity on azo-collagen and was inhibited by EDTA. The results presented in this study demonstrate the presence of proteins in the venom of P. bistriata with potential for biotechnological applications.
Collapse
|
17
|
Zare-Zardini H, Tolueinia B, Hashemi A, ebrahimi L, Fesahat F. Antioxidant and cholinesterase inhibitory activity of a new peptide from Ziziphus jujuba fruits. Am J Alzheimers Dis Other Demen 2013; 28:702-9. [PMID: 24005854 PMCID: PMC10852667 DOI: 10.1177/1533317513500839] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2024]
Abstract
Antioxidant agents and cholinesterase inhibitors are the foremost drugs for the treatment of Alzheimer's disease (AD). In this study, a new peptide from Ziziphus jujuba fruits was investigated for its inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes as well as antioxidant activity. This peptide was introduced as a new peptide and named Snakin-Z. The Snakin-Z displayed considerable cholinesterase inhibition against AChE and BChE. The half maximal inhibitory concentration (IC50) values of Snakin-Z against AChE and BChE are 0.58 ± 0.08 and 0.72 ± 0.085 mg/mL, respectively. This peptide has 80% enzyme inhibitory activity on AChE and BChE at 1.5 mg/mL. The Snakin-Z also had the high antioxidant activity (IC50 = 0.75 ± 0.09 mg/mL). Thus, it is suggested that Snakin-Z may be beneficial in the treatment of AD. However, more detailed researches are still required as in vivo testing its anticholinesterase and antioxidant activities.
Collapse
Affiliation(s)
- Hadi Zare-Zardini
- Young Researchers and Elite Club, Yazd Branch, Islamic Azad University, Yazd, Islamic Republic of Iran
- Department of Pediatric Hematology, Oncology and Genetics Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Islamic Republic of Iran
| | - Behnaz Tolueinia
- Department of biology, University of Applied Science and Technology of Sistan and Baluchestan, Minushargh Branch, Zahedan, Islamic Republic of Iran
| | - Azam Hashemi
- Department of Pediatric Hematology, Oncology and Genetics Research Center, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Islamic Republic of Iran
| | - Leila ebrahimi
- Department of Hematology, Iranian Blood Transfusion Organization, Tehran, Islamic Republic of Iran
| | - Farzaneh Fesahat
- Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Islamic Republic of Iran
- Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Islamic Republic of Iran
| |
Collapse
|